Ocular Hypertension (OHT) Treatments
Find Ocular Hypertension (OHT) Treatments
Medications for Ocular Hypertension (OHT)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Ocular Hypertension (OHT).
Found 15 Approved Drugs for Ocular Hypertension (OHT)
Timolol
Brand Names
Timoptic-XE, Betimol, Timoptic, Timolol GFS, Istalol
Timolol
Brand Names
Timoptic-XE, Betimol, Timoptic, Timolol GFS, Istalol
Form: Tablet, Solution
Method of administration: Oral, Ophthalmic
FDA approval date: June 08, 1990
Classification: beta-Adrenergic Blocker
TIMOPTIC Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Latanoprost
Brand Names
Xelpros, Iyuzeh, Xalatan
Latanoprost
Brand Names
Xelpros, Iyuzeh, Xalatan
Form: Solution
Method of administration: Ophthalmic, Topical
FDA approval date: November 15, 2010
XELPROS (latanoprost ophthalmic emulsion)
Hydrchloride
Brand Names
Salagen, Qlosi, VUITY
Hydrchloride
Brand Names
Salagen, Qlosi, VUITY
Form: Tablet, Solution
Method of administration: Oral, Ophthalmic
FDA approval date: October 14, 2005
Classification: Cholinergic Receptor Agonist
Pilocarpine hydrochloride tablets, USP are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with Sjogren's syndrome.
Cosopt
Generic Name
Dorzolamide
Cosopt
Generic Name
Dorzolamide
Form: Solution
Method of administration: Ophthalmic
FDA approval date: June 01, 2009
Classification: beta-Adrenergic Blocker
Dorzolamide hydrochloride and timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time). The IOP-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day. Dorzolamide hydrochloride and timolol maleate ophthalmic solution is a carbonic anhydrase inhibitor with a beta-adrenergic receptor blocking agent indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers., The IOP-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution twice daily was slightly less than that seen with the concomitant administration of 0.5% timolol twice daily, and 2% dorzolamide three times daily. ( 1 )
Bimatoprost
Brand Names
Lumigan, Latisse, Durysta
Bimatoprost
Brand Names
Lumigan, Latisse, Durysta
Form: Implant, Solution
Method of administration: Intracameral, Ophthalmic
FDA approval date: January 26, 2009
Classification: Prostaglandin Analog
LUMIGAN ® (bimatoprost ophthalmic solution)
Showing 1-5 of 15
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances